(0.00%) 5 213.50 points
(-0.01%) 39 024 points
(0.00%) 18 199 points
(-0.87%) $77.70
(0.41%) $2.22
(-0.09%) $2 322.20
(-0.01%) $27.54
(-0.03%) $988.10
(0.13%) $0.931
(0.41%) $10.94
(0.18%) $0.801
(0.02%) $91.46
Quarter results today
(bmo 2024-05-08)
Expected move: +/- 7.58%
-4.17% $ 1.380
@ $1.391
Emitido: 14 feb 2024 @ 11:10
Retorno: -0.79%
Señal anterior: feb 13 - 15:52
Señal anterior:
Retorno: 4.59 %
Live Chart Being Loaded With Signals
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies...
Stats | |
---|---|
Volumen de hoy | 902 219 |
Volumen promedio | 963 339 |
Capitalización de mercado | 348.34M |
EPS | $0 ( 2024-03-19 ) |
Próxima fecha de ganancias | ( $-0.0900 ) 2024-06-07 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -3.54 |
ATR14 | $0.00400 (0.29%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-02 | Perez Jeffrey Thomas | Buy | 126 713 | Common Stock |
2024-05-02 | Kirk Randal J | Buy | 8 896 412 | Common Stock |
2024-05-02 | Kirk Randal J | Buy | 6 085 471 | Common Stock |
2024-05-02 | Kirk Randal J | Sell | 691 929 | Common Stock |
2024-04-05 | Thomasian Harry Jr. | Buy | 135 714 | Common Stock |
INSIDER POWER |
---|
67.23 |
Last 99 transactions |
Buy: 22 274 780 | Sell: 4 631 433 |
Volumen Correlación
Precigen Inc Correlación
10 Correlaciones Más Positivas | |
---|---|
TATT | 0.813 |
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Precigen Inc Correlación - Moneda/Commodity
Precigen Inc Finanzas
Annual | 2023 |
Ingresos: | $6.23M |
Beneficio Bruto: | $-4.74M (-76.18 %) |
EPS: | $-0.390 |
FY | 2023 |
Ingresos: | $6.23M |
Beneficio Bruto: | $-4.74M (-76.18 %) |
EPS: | $-0.390 |
FY | 2022 |
Ingresos: | $26.91M |
Beneficio Bruto: | $20.57M (76.44 %) |
EPS: | $-0.400 |
FY | 2021 |
Ingresos: | $103.87M |
Beneficio Bruto: | $45.49M (43.79 %) |
EPS: | $-0.470 |
Financial Reports:
No articles found.
Precigen Inc
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorporates advanced DNA construction technologies and computational models to design and assemble genetic components into complex gene expression programs; mbIL15, a gene that enhances functional characteristics of immune cells; Sleeping Beauty, a non-viral transposon/transposase system; AttSite recombinases, which breaks and rejoins DNA at specific sequences; AdenoVerse technology platform, a library of engineered adenovector serotypes; and L. lactis is a food-grade bacterium. Additionally, it provides RheoSwitch, an inducible gene switch system that provides quantitative dose-proportionate regulation of the amount and timing of target protein expression; kill switches to selectively eliminate cell therapies in vivo; tissue-specific promoters; UltraCAR-T platform for the treatment of cancer; AdenoVerse Immunotherapy, a library of proprietary adenovectors for the gene delivery; and ActoBiotics platform, genetically modified bacteria that deliver proteins and peptides at mucosal sites. Precigen, Inc. has collaboration and license agreements with Alaunos Therapeutics, Inc.; Ares Trading S.A.; Oragenics, Inc.; Castle Creek Biosciences, Inc.; Intrexon Energy Partners, LLC; and Intrexon Energy Partners II, LLC. The company was formerly known as Intrexon Corporation and changed its name to Precigen, Inc. in January 2020. Precigen, Inc. was founded in 1998 and is based in Germantown, Maryland.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico